Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Medpace Holdings Inc (MEDP)

Medpace Holdings Inc (MEDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Medpace Holdings Inc 5375 MEDPACE WAY CINCINNATI OH 45227 USA

www.medpace.com P: 513-579-9911 F: 513-579-0444

Description:

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.

Key Statistics

Overview:

Market Capitalization, $K 12,162,992
Enterprise Value, $K 11,917,542
Shares Outstanding, K 30,983
Annual Sales, $ 1,886 M
Annual Net Income, $ 282,810 K
Last Quarter Sales, $ 511,040 K
Last Quarter Net Income, $ 102,590 K
EBIT, $ 382,050 K
EBITDA, $ 408,380 K
60-Month Beta 1.40
% of Insider Shareholders 20.30%
% of Institutional Shareholders 77.98%
Float, K 24,693
% Float 79.70%
Short Volume Ratio 0.50

Growth:

1-Year Return 91.05%
3-Year Return 137.52%
5-Year Return 603.28%
5-Year Revenue Growth 167.65%
5-Year Earnings Growth 242.86%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 3.20 on 04/22/24
Latest Earnings Date N/A
Earnings Per Share ttm 9.81
EPS Growth vs. Prev Qtr 30.08%
EPS Growth vs. Prev Year 40.97%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

MEDP Ratios

Ratio
Price/Earnings ttm 39.86
Price/Earnings forward 34.84
Price/Earnings to Growth 1.95
Return-on-Equity % 59.74%
Return-on-Assets % 19.70%
Profit Margin % 15.00%
Debt/Equity 0.00
Price/Sales 6.42
Price/Cash Flow 38.82
Price/Book 18.04
Book Value/Share 21.68
Interest Coverage 686.06
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar